| B cells and tertiary lymphoid structures promote immunotherapy response BA Helmink, SM Reddy, J Gao, S Zhang, R Basar, R Thakur, K Yizhak, ... Nature 577 (7791), 549-555, 2020 | 1735 | 2020 |
| Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis SA Melo, H Sugimoto, JT O’Connell, N Kato, A Villanueva, A Vidal, L Qiu, ... Cancer cell 26 (5), 707-721, 2014 | 1637 | 2014 |
| Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons … A Lucci, LM McCall, PD Beitsch, PW Whitworth, DS Reintgen, ... Journal of Clinical Oncology 25 (24), 3657-3663, 2007 | 977 | 2007 |
| Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma RN Amaria, SM Reddy, HA Tawbi, MA Davies, MI Ross, IC Glitza, ... Nature medicine 24 (11), 1649-1654, 2018 | 720 | 2018 |
| Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial LG Wilke, LM McCall, KE Posther, PW Whitworth, DS Reintgen, AM Leitch, ... Annals of surgical oncology 13, 491-500, 2006 | 700 | 2006 |
| Circulating tumour cells in non-metastatic breast cancer: a prospective study A Lucci, CS Hall, AK Lodhi, A Bhattacharyya, AE Anderson, L Xiao, ... The lancet oncology 13 (7), 688-695, 2012 | 597 | 2012 |
| International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment S Dawood, SD Merajver, P Viens, PB Vermeulen, SM Swain, TA Buchholz, ... Annals of oncology 22 (3), 515-523, 2011 | 551 | 2011 |
| Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients LG Radvanyi, C Bernatchez, M Zhang, PS Fox, P Miller, J Chacon, R Wu, ... Clinical Cancer Research 18 (24), 6758-6770, 2012 | 455 | 2012 |
| Inflammatory breast cancer: the disease, the biology, the treatment FM Robertson, M Bondy, W Yang, H Yamauchi, S Wiggins, S Kamrudin, ... CA: a cancer journal for clinicians 60 (6), 351-375, 2010 | 455 | 2010 |
| Pooled analysis of the prognostic relevance of circulating tumor cells in primary breast cancer WJ Janni, B Rack, LWMM Terstappen, JY Pierga, FA Taran, T Fehm, ... Clinical Cancer Research 22 (10), 2583-2593, 2016 | 364 | 2016 |
| Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells Y Lavie, H Cao, A Volner, A Lucci, TY Han, V Geffen, AE Giuliano, ... Journal of Biological Chemistry 272 (3), 1682-1687, 1997 | 363 | 1997 |
| Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised … RN Amaria, PA Prieto, MT Tetzlaff, A Reuben, MC Andrews, MI Ross, ... The Lancet Oncology 19 (2), 181-193, 2018 | 274 | 2018 |
| Circulating tumor cells in breast cancer patients treated by neoadjuvant chemotherapy: a meta-analysis FC Bidard, S Michiels, S Riethdorf, V Mueller, LJ Esserman, A Lucci, ... JNCI: Journal of the National Cancer Institute 110 (6), 560-567, 2018 | 267 | 2018 |
| COX-2 overexpression increases motility and invasion of breast cancer cells B Singh, JA Berry, A Shoher, V Ramakrishnan, A Lucci International journal of oncology 26 (5), 1393-1399, 2005 | 253 | 2005 |
| Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2‐positive breast cancer LS Dominici, VM Negron Gonzalez, AU Buzdar, A Lucci, EA Mittendorf, ... Cancer 116 (12), 2884-2889, 2010 | 241 | 2010 |
| Glucosylceramide: a marker for multiple-drug resistant cancers. A Lucci, WI Cho, TY Han, AE Giuliano, DL Morton, MC Cabot Anticancer research 18 (1B), 475-480, 1998 | 229 | 1998 |
| Factors influencing career choice among medical students interested in surgery A Azizzadeh, CH McCollum, CC Miller III, KM Holliday, HC Shilstone, ... Current surgery 60 (2), 210-213, 2003 | 226 | 2003 |
| A CXCR4 antagonist CTCE-9908 inhibits primary tumor growth and metastasis of breast cancer EH Huang, B Singh, M Cristofanilli, J Gelovani, C Wei, L Vincent, ... Journal of Surgical Research 155 (2), 231-236, 2009 | 214 | 2009 |
| American College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patterns AS Caudle, KK Hunt, SL Tucker, K Hoffman, SM Gainer, A Lucci, ... Annals of surgical oncology 19, 3144-3151, 2012 | 210 | 2012 |
| Identification of patients with documented pathologic complete response in the breast after neoadjuvant chemotherapy for omission of axillary surgery AB Tadros, WT Yang, S Krishnamurthy, GM Rauch, BD Smith, V Valero, ... JAMA surgery 152 (7), 665-670, 2017 | 201 | 2017 |
